Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XIAP | P98170 | 1/20 | 0.47 |
| ▸ | CASP3 | P42574 | 6/20 | 0.47 |
| ▸ | CASP2 | P42575 | 6/20 | 0.47 |
| ▸ | CALCRL | Q16602 | 2/20 | 0.45 |
| ▸ | NTSR2 | O95665 | 6/20 | 0.44 |
| ▸ | NTSR1 | P30989 | 6/20 | 0.44 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.43 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.43 |
| ▸ | SORT1 | Q99523 | 5/20 | 0.43 |
| ▸ | CMA1 | P23946 | 1/20 | 0.43 |
| ▸ | F2 | P00734 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25524189 | 0.93 | XIAP (0.53) | XIAPCALCRLNTSR2NTSR1AGTR1 | |
| SCHEMBL22484305 | 0.92 | XIAP (0.50) | XIAPCALCRLNTSR2NTSR1AGTR1 | |
| SCHEMBL22484304 | 0.92 | XIAP (0.50) | XIAPCALCRLNTSR2NTSR1AGTR1 | |
| SCHEMBL25524242 | 0.87 | AGTR2 (0.50) | XIAPCALCRLNTSR2NTSR1AGTR1 | |
| SCHEMBL30585602 | 0.82 | CMA1 (0.54) | XIAPCASP3CASP2CALCRLCMA1 | |
| SCHEMBL30067143 | 0.79 | NTSR2 (0.51) | NTSR2NTSR1SORT1 | |
| SCHEMBL29680178 | 0.79 | CALCRL (0.45) | XIAPCALCRLNTSR2NTSR1SORT1 | |
| SCHEMBL24217628 | 0.79 | CMA1 (0.44) | XIAPCALCRLAGTR1AGTR2CMA1 | |
| SCHEMBL24217630 | 0.79 | CMA1 (0.44) | XIAPCALCRLAGTR1AGTR2CMA1 | |
| SCHEMBL7396690 | 0.78 | SLC6A2 (0.46) | CASP3CASP2CALCRLCMA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4678750-A1 | REPLICON DNA, CLONING VECTOR, SCREENING KIT, SCREENING METHOD, ANTI-NOBECOVIRUS AGENT, BETA-CORONAVIRUS PROLIFERATION INHIBITOR, PAN BETA-CORONAVIRUS INHIBITOR, VIRUS PROLIFERATION INHIBITOR, HEPATITIS C VIRUS PROLIFERATION INHIBITOR, AND METHOD FOR SCREENING THERAPEUTIC AGENT FOR VIRAL INFECTIOUS DISEASE | Kagoshima University (JP) | 2026-01-14 | — | — | EP | disclosed |
| US-12517129-B2 | Exosome-mediated diagnosis of hepatitis virus infections and diseases | MOREHOUSE SCHOOL OF MEDICINE (US) | 2026-01-06 | — | — | US | disclosed |
| EP-4621409-A1 | NOVEL ANTIVIRAL PEPTIDE | Daehannupharm Co., Ltd. (KR) | 2025-09-24 | — | — | EP | disclosed |
| US-20250230194-A1 | RECOMBINANT CLASSICAL SWINE FEVER VIRUS E2 PROTEIN WITH B/C DOMAIN SWAPPING | Boehringer Ingelheim Vetmedica (China) Co., Ltd. (CN) | 2025-07-17 | — | — | US | disclosed |
| CN-120118859-A | Application of bovine LONP gene as target in regulation and control of BVDV replication | 西北农林科技大学 | 2025-06-10 | — | — | CN | disclosed |
| US-12247979-B2 | Compositions and methods for capturing exosomes | MOREHOUSE SCHOOL OF MEDICINE | 2025-03-11 | — | — | US | disclosed |
| EP-4460327-A1 | TRIPLE GENE-DELETED PSEUDORABIES VIRUS VECTORED PCV2B AND CSFV | The Board of Supervisors of Louisiana State University and Agricultural and Mechanical College (US) | 2024-11-13 | — | — | EP | disclosed |
| US-20240350610-A1 | RECOMBINANT CLASSICAL SWINE FEVER VIRUS E2 PROTEIN | Boehringer Ingelheim Vetmedica (China) Co., Ltd. (CN) | 2024-10-24 | — | — | US | disclosed |
| WO-2024214687-A1 | REPLICON DNA, CLONING VECTOR, SCREENING KIT, SCREENING METHOD, ANTI-NOBECOVIRUS AGENT, BETA-CORONAVIRUS PROLIFERATION INHIBITOR, PAN BETA-CORONAVIRUS INHIBITOR, VIRUS PROLIFERATION INHIBITOR, HEPATITIS C VIRUS PROLIFERATION INHIBITOR, AND METHOD FOR SCREENING THERAPEUTIC AGENT FOR VIRAL INFECTIOUS DISEASE | 国立大学法人 鹿児島大学 | 2024-10-17 | — | — | WO | disclosed |
| WO-2024211625-A1 | HBV GENE EDITING | ARCTURUS THERAPEUTICS, INC. (US) | 2024-10-10 | — | — | WO | disclosed |
| WO-2022146654-A1 | TRANSCRIPTION ACTIVATOR-LIKE EFFECTOR NUCLEASES (TALENS) TARGETING HBV | Janssen Pharmaceuticals, Inc. (US) | 2022-07-07 | — | — | WO | disclosed |
| US-20220193221-A1 | CSFV SUBUNIT VACCINE | BOEHRINGER INGELHEIM VETMEDICA (CHINA) CO. LTD. (CN) | 2022-06-23 | — | — | US | disclosed |
| US-11360090-B2 | Exosome-mediated diagnosis of hepatitis virus infections and diseases | MOREHOUSE SCHOOL OF MEDICINE (US) | 2022-06-14 | — | — | US | disclosed |
| WO-2022083600-A1 | RECOMBINANT CLASSICAL SWINE FEVER VIRUS E2 PROTEIN | Boehringer Ingelheim Vetmedica (China) Co., Ltd. (CN) | 2022-04-28 | — | — | WO | disclosed |
| US-11300565-B2 | Exosome-mediated diagnosis of human immunodeficiency virus infection | MOREHOUSE SCHOOL OF MEDICINE (US) | 2022-04-12 | — | — | US | disclosed |
| US-11278614-B2 | Poxviral vaccines | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2022-03-22 | — | — | US | disclosed |
| US-20220074004-A1 | HCV DETECTION | DIAGNOSTICS FOR THE REAL WORLD, LTD | 2022-03-10 | — | — | US | disclosed |
| EP-3956438-A1 | CSFV SUBUNIT VACCINE | Boehringer Ingelheim Vetmedica (China) Co., Ltd. (CN) | 2022-02-23 | — | — | EP | disclosed |
| EP-3956439-A1 | RECOMBINANT CLASSICAL SWINE FEVER VIRUS | Boehringer Ingelheim Vetmedica (China) Co., Ltd. (CN) | 2022-02-23 | — | — | EP | disclosed |
| CN-107002047-B | Pestivirus | 英特维特国际股份有限公司 | 2022-02-08 | — | — | CN | disclosed |